ArticleEJNMMI research2024
Clinical value of
Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- AVS-referenced diagnostic performance ofFrontiers in endocrinology · 2026Pooled it
- Clinical value of CXCR4-targeted PET-CT in primary aldosteronism: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2025Pooled it
- DeltaAnnals of surgical oncology · 2026Article
- Clinical value of multi-time-pointEndocrine · 2026Article
- A Novel Non-Invasive Diagnostic Tool for Determining the Subtype of Primary Aldosteronism UsingWorld journal of nuclear medicine · 2026Article
- Machine learning-based model for prediction of KCNJ5 mutation in unilateral primary aldosteronism based on [EJNMMI research · 2026Article
- Real world experience with [Frontiers in endocrinology · 2026Article
- 68 Ga-pentixafor PET/CT versus adrenal venous sampling in guiding surgical management for primary aldosteronism: a prospective cohort study on postoperative outcomes.International journal of surgery (London, England) · 2026Article
- Is CXCR4-targetedEJNMMI research · 2025Article
- The prognostic value of CXCR4 PET/CT imaging in unilateral primary aldosteronism patients after adrenalectomy.EJNMMI research · 2025Article
- Recent Development of CXCR4-Targeted Nuclear Medicine Research in Adrenocortical Tumors.Mini reviews in medicinal chemistry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundSubtype diagnosis of primary aldosteronism (PA) is used to determine treatment, and the potential utility of
methodsIn total, 25 patients with PA and bilateral lesions on CT were retrospectively evaluated. All patients underwent
resultsThe concordance rate between
conclusions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.